ETF Holdings Breakdown of PGEN

Stock NamePrecigen Inc
TickerPGEN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS74017N1054
LEI549300XCWNQU35K64G19

News associated with PGEN

Analyzing Precigen (NASDAQ:PGEN) & Biofrontera (NASDAQ:BFRI)
Biofrontera (NASDAQ:BFRI – Get Free Report) and Precigen (NASDAQ:PGEN – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Insider & Institutional Ownership 10.1% of Biofrontera shares are […] - 2025-05-12 06:14:55
Precigen, Inc. (NASDAQ:PGEN) Given Average Rating of “Moderate Buy” by Analysts
Precigen, Inc. (NASDAQ:PGEN – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The average 1-year target price among brokerages that […] - 2025-02-19 07:06:52

PGEN institutional holdings

The following institutional investment holdings of PGEN have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 142,927USD 192,951
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 142,927USD 192,951
Total =285,854 USD 385,902
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.